Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gastro-Oesophageal Junction Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00281788
What this trial is testing

Combination Chemotherapy and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer

Who this might be right for
Esophageal Cancer
Duke University 13
Testing effectiveness (Phase 2)UnknownNCT05466019
What this trial is testing

A Prospective, Single Center Clinical Study of Toripalimab Combined With FLOT Regimen for Perioperative Treatment of PD-L1 Positive Locally Advanced Resectable Gastric Cancer or Gastroesophageal Junction Adenocarcinoma (GEJ)

Who this might be right for
PD-L1 Positive Locally Advanced Patients With Resectable Gastric Cancer
The First Hospital of Jilin University 30
Not applicableStudy completedNCT00716157
What this trial is testing

Incidence and Patterns of Nausea/Vomiting With Combined Chemotherapy and Radiation

Who this might be right for
Cancer of the Head and NeckCancer of the LungCancer of the Esophagus+1 more
Thomas Jefferson University 40
Testing effectiveness (Phase 2)Study completedNCT00217581
What this trial is testing

Bevacizumab, Oxaliplatin, and Docetaxel in Treating Patients With Locally Advanced Unresectable or Metastatic Stomach or Gastroesophageal Junction Cancer

Who this might be right for
Esophageal CancerGastric Cancer
Barbara Ann Karmanos Cancer Institute 39
Not applicableUnknownNCT05053295
What this trial is testing

Investigator-initiated Pilot Study to Investigate the Efficacy and Safety of Immuncell-LC in Combination With Nivolumab (Opdivo) in Subjects With Advanced or Recurrent Gastric Cancer

Who this might be right for
Relapsed or Advanced Gastric AdenocarcinomaGastro-esophageal Junction Cancer
Gangnam Severance Hospital 20
Testing effectiveness (Phase 2)Looking for participantsNCT07689851
What this trial is testing

Chemoradiotherapy and SHR-1701 in Patients With Unresectable Gastric Cancer

Who this might be right for
Gastric Cancer (GC)Gastroesophageal Junction Adenocarcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 60
Not applicableUnknownNCT04915807
What this trial is testing

Real-world Data (RWD) of Ramucirumab Plus Paclitaxel

Who this might be right for
Gastric CancerGastroesophageal Junction Adenocarcinoma
Hallym University Medical Center 222
Early research (Phase 1)Study completedNCT04805307
What this trial is testing

Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy, Phase 1 Study of CMG901

Who this might be right for
Advanced Solid TumorGastric Cancer(Including Gastroesophageal Junction Adenocarcinoma)Pancreatic Cancer
Keymed Biosciences Co.Ltd 176
Testing effectiveness (Phase 2)UnknownNCT04819971
What this trial is testing

Study of Perioperative Chemotherapy Combined With Tislelizumab and Trastuzumab in the Treatment of GC/EGC

Who this might be right for
Stomach Cancer
The First Affiliated Hospital of Zhengzhou University 67
Large-scale testing (Phase 3)Looking for participantsNCT07522151
What this trial is testing

Clinical Study of Adebrelimab Therapy in the Perioperative Treatment of Gastric Cancer or Gastroesophageal Junction Cancer

Who this might be right for
Locally Advanced Gastric or Gastroesophageal Junction Cancer
Shanghai Shengdi Pharmaceutical Co., Ltd 874
Not applicableStudy completedNCT02415101
What this trial is testing

Timing of Resective Surgery After Neoadjuvant Chemoradiotherapy in Esophageal Cancer

Who this might be right for
Cancer of the Esophagus
Karolinska University Hospital 202
Large-scale testing (Phase 3)Study completedNCT02898077
What this trial is testing

Paclitaxel With or Without Ramucirumab (LY3009806) in Participants With Gastric or Gastroesophageal Cancer

Who this might be right for
Gastroesophageal Junction AdenocarcinomaGastric Adenocarcinoma
Eli Lilly and Company 440
Large-scale testing (Phase 3)UnknownNCT01911832
What this trial is testing

Impact of Gastric Tube Reconstruction Widths on Quality of Life for Esophagogastric Cancers

Who this might be right for
Stomach NeoplasmsEsophageal Neoplasms
West China Hospital 60
Very early researchNot Yet RecruitingNCT05447234
What this trial is testing

TCRx_T Cells for Advanced or Recurrent Gastric/Gastroesophageal Junction Cancer After Failure of First Chemotherapy

Who this might be right for
Gastric CancerGastroesophageal-junction Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine 50
Very early researchUnknownNCT05277987
What this trial is testing

An Evaluation Trial About Anti-claudin18.2 the Specificity of Chimeric Antigen Receptor T Cells in the Advanced Gastric / Esophagogastric Junction Adenocarcinoma and Pancreatic Cancer Subjects

Who this might be right for
CAR T-Cell Therapy
Shenzhen Fifth People's Hospital 18
Post-approval studies (Phase 4)Study completedNCT02426034
What this trial is testing

Apatinib Tablets in the Treatment of Advanced or Metastatic Gastric Cancer

Who this might be right for
Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
Jiangsu HengRui Medicine Co., Ltd. 2,004
Testing effectiveness (Phase 2)Looking for participantsNCT06121700
What this trial is testing

Radiotherapy + Chemoimmunotherapy Followed by Surgery in Patients With Limited Metastatic Gastric or GEJ Cancer

Who this might be right for
AdenocarcinomaStomach NeoplasmGastroesophageal-junction Cancer+6 more
Fudan University 55
Testing effectiveness (Phase 2)Looking for participantsNCT04656041
What this trial is testing

Folfox+Irinotecan+Chemort In Esophageal Cancer

Who this might be right for
Gastroesophageal Junction AdenocarcinomaEsophagogastric Cancer
Massachusetts General Hospital 40
Testing effectiveness (Phase 2)Ended earlyNCT02530437
What this trial is testing

Taladegib, Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Localized Esophageal or Gastroesophageal Junction Cancer

Who this might be right for
Gastroesophageal Junction AdenocarcinomaStage IB Esophageal Adenocarcinoma AJCC v7Stage II Esophageal Adenocarcinoma AJCC v7+4 more
M.D. Anderson Cancer Center 7
Testing effectiveness (Phase 2)Active Not RecruitingNCT06693128
What this trial is testing

Camrelizumab Combined With or Without Apatinib and SOX of Neoadjuvant Treatment for Gastric Cancer

Who this might be right for
Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma
Ruijin Hospital 80
Next Page